Accel

Accel is a venture capital firm founded in 1983 and headquartered in Palo Alto, California, with additional offices in San Francisco, London, and Bangalore. The firm specializes in early and growth-stage investments, focusing on sectors such as cloud computing, software as a service (SaaS), consumer products, enterprise solutions, information technology, healthcare, fintech, security, media, and business services. Accel is dedicated to supporting a global community of entrepreneurs, identifying and backing those with the potential to drive the growth of next-generation industries. The firm's portfolio includes notable companies like Atlassian, Dropbox, and Facebook, showcasing its commitment to fostering innovation and growth in the technology landscape.

Radhika Ananth

Vice President and Investor

Mahendran Balachandran

Partner, India

Julien Bek

Principal

Luca Bocchio

Partner

Philippe Botteri

Partner

Andrei Brasoveanu

Partner

Katie Brown

Investor

Abhinav Chaturvedi

Partner

Ethan Choi

Partner

Miles Clements

Partner

Adrian Colyer

Venture Partner

Kevin Comolli

Partner

Anand Daniel

Partner

Ben Dooley

CFO

Christine Esserman

Partner

Sameer Gandhi

Partner

Martin Gibson

Technology Investor

Bruce Golden

Partner

Sara Ittelson

Partner

Myrel Iturrey

Investor

Shekhar Kirani

Partner, India

Gagan Kumar

General Partner

Daniel Levine

Partner

Zhenya Loginov

Partner

Steve Loughlin

Partner

Arun Mathew

Partner

Jonathan Mendelson

Investor

Gonzalo Mocorrea

Investor

Vasant Natarajan

Partner

Vas Natarajan

Partner

Nate Niparko

Partner

Maya S. Noeth

Partner

Rachit Parekh

Investor

Vijaysai Patnaik

Associate

Prashanth Prakash

Co-Founder and Partner, India

Varun Purandare

Principal and Investor

Ben Quazzo

Investor, Venture and Growth

Rafael Quintanilla Loeillet

Early-Stage Investor

Tim Rawlinson

Investor - Growth

Matthew Robinson

Investor

Tracy Sedlock

Chief Operating Partner

Ajay Sethi

Venture Partner

Karan Shah

Investor

Manasi Shah

Vice President and Investment Team Member

Sarthak Singh

Investor

Robert Sternberg

Investor

Barath Shankar Subramanian

Senior Analyst

Prayank Swaroop

Partner

Charles Tananbaum

Investor

Humza Tariq

Investor

Jonathan Turner

Partner

Cecilia Wang

Vice President and Investor

Matt Weigand

Partner

Eric Wolford

Venture Partner

Richard Wong

Partner

Ivan Zhou

Partner

David Waltcher

Investor

Past deals in Health Care

Kry

Venture Round in 2022
Kry is a digital healthcare company founded in 2015 and headquartered in Stockholms Lan, Sweden. It specializes in providing a digital health application that enables patients to consult qualified healthcare professionals via video consultations on their smartphones or tablets. This service allows users to access healthcare conveniently and promptly, offering consultations in minutes, regardless of their location. By facilitating direct interaction between patients and healthcare providers, Kry aims to empower individuals to make informed choices about their health while alleviating the demands on traditional healthcare systems.

Zumutor Biologics

Series A in 2021
Zumutor Biologics Inc. is an immuno-oncology company specializing in the development of innovative therapies targeting innate immunity and the tumor microenvironment. Founded in 2013 and headquartered in Cambridge, Massachusetts, with a research and development center in Bengaluru, India, Zumutor creates high-diversity human antibody libraries to discover novel immunotherapies and enhance monoclonal antibodies. The company focuses on developing biologic products for various cancers, including breast cancer, prostate cancer, and lymphoma, as well as other undisclosed indications. Zumutor's proprietary antibody engineering platforms enable the advancement of targeted cell therapeutics aimed at improving treatment outcomes in cancer patients.

Lucid Lane

Series A in 2021
Lucid Lane, Inc. is a telehealth provider based in Los Altos, California, specializing in services for individuals with medication dependence and substance use disorders. Founded in 2017, the company offers a comprehensive approach that combines data-driven personalized health planning, real-time interventions, and coach-based support. Lucid Lane's services facilitate ongoing access to therapists and utilize advanced technologies for continuous measurement and monitoring, enabling tailored treatment plans and timely interventions. By providing a safe and private environment for mental health therapy, pain relief, and relapse prevention, Lucid Lane aims to empower individuals to successfully manage their conditions and lead healthier lives.

Veri

Seed Round in 2021
Veri is a company focused on enhancing metabolic health for health-conscious individuals through innovative technology. It has developed a blood sugar monitoring application that integrates with a sensor to provide real-time tracking of blood sugar levels. The application offers users comprehensive analysis and insights related to their glucose readings, empowering them to make informed decisions about their eating habits. By facilitating a better understanding of what, when, and how to eat, Veri aims to help individuals stabilize their blood sugar levels and lead healthier lifestyles.

Kry

Series D in 2021
Kry is a digital healthcare company founded in 2015 and headquartered in Stockholms Lan, Sweden. It specializes in providing a digital health application that enables patients to consult qualified healthcare professionals via video consultations on their smartphones or tablets. This service allows users to access healthcare conveniently and promptly, offering consultations in minutes, regardless of their location. By facilitating direct interaction between patients and healthcare providers, Kry aims to empower individuals to make informed choices about their health while alleviating the demands on traditional healthcare systems.

Kry

Series C in 2020
Kry is a digital healthcare company founded in 2015 and headquartered in Stockholms Lan, Sweden. It specializes in providing a digital health application that enables patients to consult qualified healthcare professionals via video consultations on their smartphones or tablets. This service allows users to access healthcare conveniently and promptly, offering consultations in minutes, regardless of their location. By facilitating direct interaction between patients and healthcare providers, Kry aims to empower individuals to make informed choices about their health while alleviating the demands on traditional healthcare systems.

Zumutor Biologics

Series A in 2019
Zumutor Biologics Inc. is an immuno-oncology company specializing in the development of innovative therapies targeting innate immunity and the tumor microenvironment. Founded in 2013 and headquartered in Cambridge, Massachusetts, with a research and development center in Bengaluru, India, Zumutor creates high-diversity human antibody libraries to discover novel immunotherapies and enhance monoclonal antibodies. The company focuses on developing biologic products for various cancers, including breast cancer, prostate cancer, and lymphoma, as well as other undisclosed indications. Zumutor's proprietary antibody engineering platforms enable the advancement of targeted cell therapeutics aimed at improving treatment outcomes in cancer patients.

Nines

Series A in 2019
Nines is the first-of-its-kind teleradiology practice. Our radiologists and engineers are on a mission to build world-class tools in-house to enable the best radiologists to deliver the best patient care.

Acko

Series C in 2019
Acko is a digital insurance provider that offers a range of personalized insurance products through its online platform. Focused on creating transparency and ease in the insurance purchasing process, Acko utilizes data and analytics to underwrite and distribute its offerings. The company specializes in bite-sized insurance products tailored for drivers and individuals in transportation, and has expanded its services to include healthcare-related policies. Acko aims to deliver seamless access to auto insurance, employee health benefits, and various other insurance products, ensuring a user-friendly experience for consumers.

Farcast

Series C in 2018
Farcast Biosciences Inc is a clinical diagnostic company focused on improving cancer treatment through innovative testing methods. Founded in 2019 and based in Madison, Wisconsin, the company has developed a human tumor microenvironment platform that preserves fresh, unmodified tumor fragments. This technology allows oncologists to evaluate individual tumors and determine the most effective treatment options for patients before therapy begins. Additionally, Farcast's platform provides valuable data for drug developers and researchers, facilitating the analysis of tumor response profiles. The company aims to enhance precision therapeutics and diagnostics by generating high-fidelity insights from live human tumors, ultimately helping to predict patient responses to treatments.

Kry

Series B in 2018
Kry is a digital healthcare company founded in 2015 and headquartered in Stockholms Lan, Sweden. It specializes in providing a digital health application that enables patients to consult qualified healthcare professionals via video consultations on their smartphones or tablets. This service allows users to access healthcare conveniently and promptly, offering consultations in minutes, regardless of their location. By facilitating direct interaction between patients and healthcare providers, Kry aims to empower individuals to make informed choices about their health while alleviating the demands on traditional healthcare systems.

Nines

Seed Round in 2017
Nines is the first-of-its-kind teleradiology practice. Our radiologists and engineers are on a mission to build world-class tools in-house to enable the best radiologists to deliver the best patient care.

Kry

Series A in 2017
Kry is a digital healthcare company founded in 2015 and headquartered in Stockholms Lan, Sweden. It specializes in providing a digital health application that enables patients to consult qualified healthcare professionals via video consultations on their smartphones or tablets. This service allows users to access healthcare conveniently and promptly, offering consultations in minutes, regardless of their location. By facilitating direct interaction between patients and healthcare providers, Kry aims to empower individuals to make informed choices about their health while alleviating the demands on traditional healthcare systems.

Acko

Seed Round in 2017
Acko is a digital insurance provider that offers a range of personalized insurance products through its online platform. Focused on creating transparency and ease in the insurance purchasing process, Acko utilizes data and analytics to underwrite and distribute its offerings. The company specializes in bite-sized insurance products tailored for drivers and individuals in transportation, and has expanded its services to include healthcare-related policies. Acko aims to deliver seamless access to auto insurance, employee health benefits, and various other insurance products, ensuring a user-friendly experience for consumers.

Amino

Series C in 2017
Amino Inc. operates an online platform designed to assist users in finding doctors, comparing their qualifications, and booking appointments within the United States. The platform allows patients to search for healthcare providers based on various conditions, procedures, and specialties, thus facilitating informed decisions regarding their healthcare. Established in 2013 and headquartered in San Francisco, California, Amino aims to enhance healthcare financial wellness for companies and their employees by simplifying the navigation of the complex US healthcare system. By leveraging data-driven, individualized care suggestions, the company strives to make high-value healthcare benefits more accessible and intuitive for its users. Formerly known as Pare Labs, Inc., Amino rebranded in May 2014 to better reflect its focus on improving the healthcare experience.

DailyRounds

Seed Round in 2016
DailyRouds. is a mobile app exclusively for Doctors. Medical Schools, Physician & Surgeon societies and individual Doctors can publish clinical cases, articles and images after peer review. The app offers doctor analytics, sentiments and sponsored case studies for the pharma and medical devices industry. The network of Doctors created can be leveraged to build EHR, Doctor networking and many other healthcare solutions.

Farcast

Series B in 2016
Farcast Biosciences Inc is a clinical diagnostic company focused on improving cancer treatment through innovative testing methods. Founded in 2019 and based in Madison, Wisconsin, the company has developed a human tumor microenvironment platform that preserves fresh, unmodified tumor fragments. This technology allows oncologists to evaluate individual tumors and determine the most effective treatment options for patients before therapy begins. Additionally, Farcast's platform provides valuable data for drug developers and researchers, facilitating the analysis of tumor response profiles. The company aims to enhance precision therapeutics and diagnostics by generating high-fidelity insights from live human tumors, ultimately helping to predict patient responses to treatments.

Zumutor Biologics

Seed Round in 2016
Zumutor Biologics Inc. is an immuno-oncology company specializing in the development of innovative therapies targeting innate immunity and the tumor microenvironment. Founded in 2013 and headquartered in Cambridge, Massachusetts, with a research and development center in Bengaluru, India, Zumutor creates high-diversity human antibody libraries to discover novel immunotherapies and enhance monoclonal antibodies. The company focuses on developing biologic products for various cancers, including breast cancer, prostate cancer, and lymphoma, as well as other undisclosed indications. Zumutor's proprietary antibody engineering platforms enable the advancement of targeted cell therapeutics aimed at improving treatment outcomes in cancer patients.

Amino

Series B in 2015
Amino Inc. operates an online platform designed to assist users in finding doctors, comparing their qualifications, and booking appointments within the United States. The platform allows patients to search for healthcare providers based on various conditions, procedures, and specialties, thus facilitating informed decisions regarding their healthcare. Established in 2013 and headquartered in San Francisco, California, Amino aims to enhance healthcare financial wellness for companies and their employees by simplifying the navigation of the complex US healthcare system. By leveraging data-driven, individualized care suggestions, the company strives to make high-value healthcare benefits more accessible and intuitive for its users. Formerly known as Pare Labs, Inc., Amino rebranded in May 2014 to better reflect its focus on improving the healthcare experience.

Amino

Series A in 2014
Amino Inc. operates an online platform designed to assist users in finding doctors, comparing their qualifications, and booking appointments within the United States. The platform allows patients to search for healthcare providers based on various conditions, procedures, and specialties, thus facilitating informed decisions regarding their healthcare. Established in 2013 and headquartered in San Francisco, California, Amino aims to enhance healthcare financial wellness for companies and their employees by simplifying the navigation of the complex US healthcare system. By leveraging data-driven, individualized care suggestions, the company strives to make high-value healthcare benefits more accessible and intuitive for its users. Formerly known as Pare Labs, Inc., Amino rebranded in May 2014 to better reflect its focus on improving the healthcare experience.

Farcast

Series B in 2013
Farcast Biosciences Inc is a clinical diagnostic company focused on improving cancer treatment through innovative testing methods. Founded in 2019 and based in Madison, Wisconsin, the company has developed a human tumor microenvironment platform that preserves fresh, unmodified tumor fragments. This technology allows oncologists to evaluate individual tumors and determine the most effective treatment options for patients before therapy begins. Additionally, Farcast's platform provides valuable data for drug developers and researchers, facilitating the analysis of tumor response profiles. The company aims to enhance precision therapeutics and diagnostics by generating high-fidelity insights from live human tumors, ultimately helping to predict patient responses to treatments.

Azumio

Series A in 2011
Azumio Inc. is a Palo Alto, California-based developer of health and fitness mobile applications aimed at improving overall human health. Founded in 2011, the company offers a range of applications, including Instant Heart Rate, Fitness Buddy, and the Argus platform. Argus serves as a comprehensive lifestyle service that facilitates activity and diet tracking while fostering a social network centered on health and fitness. The platform integrates various applications, such as Sleep Time and Glucose Buddy, and also connects with third-party wearable devices. Azumio leverages advanced technologies, including AI and deep learning, to enhance food recognition and provide users with valuable insights into their health and wellbeing.

Farcast

Series A in 2010
Farcast Biosciences Inc is a clinical diagnostic company focused on improving cancer treatment through innovative testing methods. Founded in 2019 and based in Madison, Wisconsin, the company has developed a human tumor microenvironment platform that preserves fresh, unmodified tumor fragments. This technology allows oncologists to evaluate individual tumors and determine the most effective treatment options for patients before therapy begins. Additionally, Farcast's platform provides valuable data for drug developers and researchers, facilitating the analysis of tumor response profiles. The company aims to enhance precision therapeutics and diagnostics by generating high-fidelity insights from live human tumors, ultimately helping to predict patient responses to treatments.

HealthcareMagic

Series A in 2009
HealthcareMagic is a fast-growing consumer-centric health company founded to transform how people approach their health and wellness. HealthcareMagic is now the largest website where people get answers from Doctors, around the world, around the clock.

Wily Technology

Series C in 2003
Wily Technology, Inc. is a provider of enterprise application management solutions, serving a diverse array of sectors including financial services, telecommunications, insurance, government, and healthcare. The company specializes in products that help organizations monitor and manage the health and availability of their web applications and infrastructure. Its key offerings include Introscope, a performance management tool; Customer Experience Manager, which identifies customer transaction issues; Portal Manager, an enterprise portal management solution; and Web Services Manager, designed for comprehensive performance management of web services. Founded in 1998 and headquartered in Brisbane, California, Wily Technology also has offices in Japan, Singapore, the United Kingdom, Germany, and France. In 2006, it became a subsidiary of CA, Inc.

Wily Technology

Venture Round in 2001
Wily Technology, Inc. is a provider of enterprise application management solutions, serving a diverse array of sectors including financial services, telecommunications, insurance, government, and healthcare. The company specializes in products that help organizations monitor and manage the health and availability of their web applications and infrastructure. Its key offerings include Introscope, a performance management tool; Customer Experience Manager, which identifies customer transaction issues; Portal Manager, an enterprise portal management solution; and Web Services Manager, designed for comprehensive performance management of web services. Founded in 1998 and headquartered in Brisbane, California, Wily Technology also has offices in Japan, Singapore, the United Kingdom, Germany, and France. In 2006, it became a subsidiary of CA, Inc.

Wily Technology

Series B in 2000
Wily Technology, Inc. is a provider of enterprise application management solutions, serving a diverse array of sectors including financial services, telecommunications, insurance, government, and healthcare. The company specializes in products that help organizations monitor and manage the health and availability of their web applications and infrastructure. Its key offerings include Introscope, a performance management tool; Customer Experience Manager, which identifies customer transaction issues; Portal Manager, an enterprise portal management solution; and Web Services Manager, designed for comprehensive performance management of web services. Founded in 1998 and headquartered in Brisbane, California, Wily Technology also has offices in Japan, Singapore, the United Kingdom, Germany, and France. In 2006, it became a subsidiary of CA, Inc.

WellTheory

WellTheory is a virtual care platform dedicated to providing comprehensive services for individuals with autoimmune and inflammatory conditions. The company focuses on supporting clients throughout their immunological journey by offering a membership experience that integrates community care, dietary and lifestyle modifications, personalized insights, and evidence-based recommendations. This holistic approach aims to empower individuals with the necessary tools and knowledge to manage their health effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.